Stocks/AKAM

AKAM three-lens brief

Evidence-based stock research on AKAM. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

52-week rangeas of 07:00 ET
$77.37$86.68$165.45

Performance

1W
+0.9%
1M
-14.7%
3M
-30.8%
6M
-42.5%
YTD
-0.7%
1Y
-3.8%
3Y
—
5Y
—
AKAM · Nightly brief
Inspect

Moved +3.52% yesterday. · Trading at 11% of its 52-week range — deep in the lower band.

  • Moved +3.52% yesterday.
  • Trading at 11% of its 52-week range — deep in the lower band.
  • 50-day MA below 200-day MA (death-cross regime); price below both.
  • Underperforming SPY by 18.1pp over 30 days.
  • Analyst mean target $130.39 — 50% above current (21 analysts).

AKAM closed at $86.68 (+3.52%) as of 2026-11-12. Market cap: $12.50B. P/E (trailing) 33.7. Price is below the 50-day MA and below the 200-day MA. Positives: moved +3.52% yesterday.; analyst mean target $130.39 — 50% above current (21 analysts).. Concerns: trading at 11% of its 52-week range — deep in the lower band.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $1.12B, net income $117.10M, free cash flow $190.03M.

Market ✓· Fundamentals ✓· 1 events
Informational only · Not investment advice
Three-lens method

Why three lenses on AKAM, not one.

A single reasoning model has blind spots it doesn’t know about. We examine AKAM across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://www.clearpathinvest.app/embed/AKAM"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath AKAM brief"></iframe>